Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
3 weeks 13 hours ago
7 weeks 23 hours ago
8 weeks 1 day ago
8 weeks 1 day ago
29 weeks 2 days ago
33 weeks 3 days ago
35 weeks 4 hours ago
35 weeks 23 hours ago
47 weeks 3 days ago
1 year 1 week ago